The global infection control market is projected to reach USD 21.06 billion by 2022 from USD 15.35 billion in 2017, at a CAGR of 6.5% during the forecast period

LONDON, Jan. 9, 2018 /PRNewswire/ -- Download the full report: https://www.reportbuyer.com/product/4230312


The factors expected to drive the market include increasing focus on outsourcing of sterilization processes among pharmaceutical companies, hospitals, and medical device manufacturers; increasing prevalence of hospital-acquired infections; growth in the number of surgical procedures; and rising focus on food sterilization. However, the harmful effects of ethylene oxide may hinder the growth of the infection control market to some extent.

The sterilization products and services segment is expected to grow at the highest CAGR during the forecast period
On the basis of products and services, the infection control market is segmented into disinfection products and sterilization products and services. The sterilization products and services segment is expected to register the highest CAGR during the forecast period. Factors such as the growing need for reducing hospital stays and healthcare costs, rising number of transmittable and antibiotic-resistant infectious diseases, growing government emphasis on infection control measures, and the augmented regulatory requirements emphasizing the need for proper sterilization are the reasons propelling the growth of this market.

The hospitals & clinics segment accounted for the largest share of the infection control in 2016
Based on end user, the global infection control market is segmented into hospitals & clinics, medical devices companies, food industry, life sciences industry, pharmaceutical companies, and other end users. In 2016, the hospitals & clinics segment dominated the infection control market. The large share of this end-user segment is mainly due to the increasing adoption of single-use medical devices, increasing need for medical device disinfection and sterilization, and improving hospital infrastructure in emerging geographies.

The Asia Pacific to register the highest growth rate in the infection control market during the forecast period
North America accounted for the largest share of the infection control market, followed by Europe, Asia Pacific, Latin America, and the Middle East & Africa. However, the Asia Pacific region is expected to grow at the highest CAGR during the forecast period.

High growth in the Asia Pacific region is largely driven by rising incidence of HAIs and increasing medical tourism in emerging countries such as China and India. Furthermore, the growing economies of China and India, increasing incidence of nosocomial infections, and improved healthcare infrastructure in Asian countries are further boosting the infection control products and services in this region during the forecast period.

Break of primary participants was as mentioned below:
• By Company Type – Tier 1–42%, Tier 2–38% and Tier 3–20%
• By Designation – C-level–40%, Director Level–35%, Others–25%
• By Region – North America–35%, Europe–30%, Asia Pacific–20%, RoW–15%

The major players in the infection control market are STERIS (UK), Getinge (Sweden), Ecolab (US), 3M (US), and Advanced Sterilization Products (US), Cantel Medical (US), Sotera Health (US), MMM Group (Germany), Matachana (Spain), Belimed AG (Switzerland), Halyard Health (US), Metrex Research (US), Reckitt Benckiser (UK), and Pal International (UK).

Research Coverage:
The report analyzes the infection control market and aims at estimating the market size and future growth potential of this market based on various segments such as product & service and end user.

The report also includes an in-depth regulatory analysis for various regions across the globe and competitive analysis of the key players in this market along with their company profiles, product and service offerings, recent developments, and key market strategies. This report also provides market information on North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.

Reasons to Buy the Report
The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn would help garner a greater share. Firms purchasing the report could use one or any combination of the below-mentioned five strategies.

This report provides insights on the following pointers:
• Market Penetration: Comprehensive information on service portfolios offered by the top players in the infection control market. This report analyzes the market by products and services, end user, and region
• Product Development/Innovation: Detailed insights on the upcoming trends and service launches in the infection control market
• Market Development: Comprehensive information about the lucrative emerging markets for infection control
• Market Diversification: Exhaustive information about new services, growing regions, recent developments, and investments in the infection control market
• Competitive Assessment: In-depth assessment of market shares, growth strategies, products, services, and technological capabilities of the leading players in the infection control market

Download the full report: https://www.reportbuyer.com/product/4230312

About Reportbuyer
Reportbuyer is a leading industry intelligence solution that provides all market research reports from top publishers

For more information:
Sarah Smith
Research Advisor at Reportbuyer.com
Email: sarah@reportbuyer.com  
Tel: +1 (646) 453 6293
Website: www.reportbuyer.com

View original content:http://www.prnewswire.com/news-releases/the-global-infection-control-market-is-projected-to-reach-usd-2106-billion-by-2022-from-usd-1535-billion-in-2017-at-a-cagr-of-65-during-the-forecast-period-300580327.html

SOURCE ReportBuyer